Podchaser Logo
Home
#9 Alternatives to Antibiotics - A talk with Alexander Belcredi, CEO and Founder of Phagomed

#9 Alternatives to Antibiotics - A talk with Alexander Belcredi, CEO and Founder of Phagomed

Released Wednesday, 1st April 2020
Good episode? Give it some love!
#9 Alternatives to Antibiotics - A talk with Alexander Belcredi, CEO and Founder of Phagomed

#9 Alternatives to Antibiotics - A talk with Alexander Belcredi, CEO and Founder of Phagomed

#9 Alternatives to Antibiotics - A talk with Alexander Belcredi, CEO and Founder of Phagomed

#9 Alternatives to Antibiotics - A talk with Alexander Belcredi, CEO and Founder of Phagomed

Wednesday, 1st April 2020
Good episode? Give it some love!
Rate Episode

These days there is a lot of discussion about the development of diagnostics, therapeutics, and vaccines against the Coronavirus and its disease COVID 19. Viruses are one threat to the health of human beings, and bacteria are another one. Traditionally, bacterial infections are treated with antibiotics, and recently, some bacteria have developed antibiotic resistance.

The WHO describes that Antibiotic resistance is one of the biggest threats to global health, food security, and development today. (https://www.who.int/news-room/fact-sheets/detail/antibiotic-resistance)

Phagomed (https://www.phagomed.com/) is developing a novel approach to treat bacterial infections without antibiotics. How that works, the challenges a company has to face while developing novel drugs, and why not all viruses are evil, you will hear in this episode.

Timestamps:
(00:00) Opening
(02:26) Intro Alexander Belcredi
(03:30) Foundation of Phagomed
(06:45) Phages – An Alternative to Antibiotics
(08:10) The Different Types of Viruses
(09:20) Why Are There Not Sufficient Solutions against Bacterial Infections?
(10:50) Competitive Landscape in the Anti-bacterial Industry
(12:30) Status of Clinical Development of Phage-Based Therapies in April 2020
(14:35) Are there Registered Phage-Based Therapies on the Market in 2020?
(16:30) How Capital Intensive is the Development of Phage-Based Therapies
(18:15) Funding Sources For Early-Stage Companies in Europe
(20:00) How to Prepare for Fundraising?
(23:30) When is the right time to go on the Market for Fundraising?
(25:00) What are the right expectations for fundraising processes? What is the success rate?
(30:45) What was the biggest challenge for Phagomed in Fundraising Phases?
(32:30) Is there a suitable time for Fundraising?
(35:20) How Long Does it Take from Starting a Financing Round to The Closing?
(36:55) Raising a Series A in 2020 – Resulted in an Acquisition in 2021
(37:55) Milestone Planning for a Series A Round
(39:05) European Public Funds to Leverage Private Investments
(42:25) What Advice Would you Give Your Younger Self Who Is at the Beginning of His Journey?

Shownotes @ PodcastNotes:
Link

More information:  
https://www.phagomed.com/
https://www.lifescienceget2gether.com/
https://linktr.ee/soschner

Video to the episode:
https://youtu.be/YHTR8yMoC3w

Do you want to learn more about life science?
Join exclusive future webinars and member-only events: Become a member of the LSG2G Network.

Join today: https://lsg2g.substack.com/subscribe


How to Start a Podcast Guide: The Complete Guide
Learn how to plan, record, and launch your podcast with this illustrated guide.

Support the Show.

Join the Podcast Newsletter: Link

Show More
Rate

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more

Episode Tags

Do you host or manage this podcast?
Claim and edit this page to your liking.
,

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features